Molecular Biology of Polycythemia and Thrombocytosis



Status:Recruiting
Conditions:Hematology
Therapuetic Areas:Hematology
Healthy:No
Age Range:Any
Updated:11/14/2018
Start Date:July 2006
End Date:July 2020
Contact:Josef T Prchal, MD
Email:josef.prchal@hsc.utah.edu
Phone:801-581-4220

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
Our study is designed to characterize the clinical picture and genetic pattern of
Polycythemia and Thrombocytosis. The purpose of this project is to find a gene and its
mutation that causes these disorders. When this is accomplished, new therapies to control and
eventually cure the disorder can be designed.

Our hypothesis is that genes and their mutation are causative of certain types of
polycythemia and thrombocytosis. These will be sought for by genetic and cell biology means.
The purpose of the study is to identify the molecular defect of these disorders.

5-7 teaspoons of peripheral blood will be drawn on all study subjects. After DNA is obtained,
linkage analysis and/or mutation analysis will be performed.

Inclusion Criteria:

1. Subjects with an elevated hemoglobin concentration (>18 in males and >16 in females)

2. Subjects with an elevated platelet count (>450,000)

Exclusion Criteria:

1. Subjects who have a known acquired cause of polycythemia and thrombocytosis

2. Subjects with heart disease, left to right heart shunt or severe pulmonary disease
We found this trial at
1
site
University of Utah
201 Presidents Circle
Salt Lake City, Utah 84108
801) 581-7200
Principal Investigator: Josef T Prchal, MD
Phone: 801-581-4220
University of Utah Research is a major component in the life of the U benefiting...
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials